Overview

Contrast-Enhanced Ultrasonography in Diagnosing Early-Stage Ovarian Cancer in Patients With an Adnexal Mass Undergoing Surgery to Remove the Ovary

Status:
Completed

Trial end date:
2012-02-01

Target enrollment:

Participant gender:

Summary

RATIONALE: New diagnostic procedures, such as contrast-enhanced ultrasonography, may be an effective method of finding ovarian cancer. PURPOSE: This clinical trial is studying how well contrast-enhanced ultrasonography works in diagnosing early-stage ovarian cancer in patients with an adnexal mass undergoing surgery to remove the ovary.

Phase:

Phase 1

Details

Lead Sponsor:

Icahn School of Medicine at Mount Sinai
Vanderbilt-Ingram Cancer Center

Collaborator:

National Cancer Institute (NCI)